Are monoamine metabolites in cerebrospinal fluid worth measuring?
Potter
W Z
WZ
Section on Clinical Pharmacology, National Institute of Mental Health, Bethesda, MD 20892.
Manji
H K
HK
D000818:Animals; D001921:Brain / Q000378:metabolism; D004298:Dopamine / Q000502:physiology; D006719:Homovanillic Acid / Q000134:cerebrospinal fluid*; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid*; D001523:Mental Disorders / Q000134:cerebrospinal fluid* / Q000378:metabolism / Q000503:physiopathology; D008734:Methoxyhydroxyphenylglycol / Q000134:cerebrospinal fluid*; D051381:Rats; D012107:Research Design / Q000592:standards; D012559:Schizophrenia / Q000134:cerebrospinal fluid / Q000378:metabolism / Q000503:physiopathology; D012701:Serotonin / Q000502:physiology
D012701:Serotonin; D008734:Methoxyhydroxyphenylglycol; D006897:Hydroxyindoleacetic Acid; D004298:Dopamine; D006719:Homovanillic Acid